Combining Medications to Enhance Depression Outcomes (CO-MED)

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Major Depressive Disorder
2		Additional conditions recognized in this trial
			Depression
			Depressive Disorder
			Depressive Disorder, Major
3		More general conditions related to this trial
			Behavioral Symptoms
			Mental Disorders
			Mood Disorders
4		Additional drug interventions recognized in this trial
			Bupropion
			Citalopram
			Dexetimide
			Mirtazapine
			Venlafaxine
5		More general drug interventions related to this trial
			Adrenergic Agents
			Adrenergic alpha-Antagonists
			Adrenergic Antagonists
			Anti-Dyskinesia Agents
			Antidepressive Agents
			Antidepressive Agents, Second-Generation
			Antidepressive Agents, Tricyclic
			Antiparkinson Agents
			Autonomic Agents
			Central Nervous System Agents
			Cholinergic Agents
			Cholinergic Antagonists
			Dopamine Agents
			Dopamine Uptake Inhibitors
			Histamine Agents
			Histamine Antagonists
			Histamine H1 Antagonists
			Molecular Mechanisms of Pharmacological Action
			Muscarinic Antagonists
			Neurotransmitter Agents
			Neurotransmitter Uptake Inhibitors
			Parasympatholytics
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Psychotropic Drugs
			Serotonin Agents
			Serotonin Uptake Inhibitors
			Therapeutic Uses
6		Sponsors listed in this trial
			National Institute of Mental Health (NIMH)